FOSL2 has been identified to promote VEGF-independent angiogenesis in fibroblasts [87], and FOSL2 knock down in glioma endothelial cells increased blood tumor barrier permeability [88]. This evidence concerns the gene FOSL2 and central nervous system cancer.